GL1X · GenesisL1 explorer

Research workbench

Structure of cetuximab with aminoheptanoic acid-linked N-butylarginine meditope variant

Analyse Structure of cetuximab with aminoheptanoic acid-linked N-butylarginine meditope… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6AU5
Type
protein
Length
885 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cetuximab Fab light chain; Cetuximab Fab heavy chain; Meditope
UniProt
P01834, S6B291
Ligands
SO4
Pockets
8 · best druggability 0.72

Structure

x-ray diffraction · 4 distinct chains · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACetuximab Fab light chainprotein2126% helix, 50% strandP01834
B, DCetuximab Fab heavy chainprotein2207% helix, 51% strandS6B291
CCetuximab Fab light chainprotein2136% helix, 51% strandP01834
E, FMeditopeprotein100% helix, 40% strand—

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 3 copies · chains B, C, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16760.720.7984empty
23430.600.7750empty
33220.600.7842empty
41430.450.7623empty
51180.410.7625empty

Interfaces

7 interfaces between chains.

  • C–D · 1868 Ų buried · 19 hydrogen bonds · protein-protein
  • A–B · 1852 Ų buried · 19 hydrogen bonds · protein-protein
  • A–C · 685 Ų buried · 8 hydrogen bonds · protein-protein
  • D–F · 495 Ų buried · 5 hydrogen bonds · protein-protein
  • B–E · 488 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide, 2 modified (disulfide, nonstandard).

Compared structures

  • 6AU5 · Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant · the same entry in another collection · chain F against F, TM-score 1.00
  • P01834 · AlphaFold monomer V2.0 prediction for immunoglobulin kappa constant (P01834) · a predicted model of the same protein · chain C against A, TM-score 0.50

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.